PAS
VIR icon

Point72 Asia (Singapore)’s Vir Biotechnology VIR Stock Holding History

Point72 Asia (Singapore)’s Portfolio VIR Stock Details VIR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-5,690
Closed -$41.8K – 1228
2024
Q4 		$41.8K Buy
+5,690
New +$44.9K 0.01% 540
2024
Q3 		– Sell
-18,959
Closed -$169K – 1350
2024
Q2 		$169K Buy
18,959
+15,755
+492% +$151K 0.04% 341
2024
Q1 		$32.5K Buy
+3,204
New +$32.6K 0.01% 900

Other funds holding VIR

SIAU
SB Investment Advisers (UK) London, United Kingdom $7.66B AUM 20.12% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Point72 Asia (Singapore)'s VIR Position: Q1 2025 in Review

Point72 Asia (Singapore) sold out of Vir Biotechnology (VIR) in Q1 2025, closing a stake of 5,690 shares — an estimated $41.8K sold.

Point72 Asia (Singapore) first reported a position in VIR in Q1 2024 and held it in 3 quarters. The position peaked at $169K in Q2 2024. 233 funds tracked by Wall St. Rank hold VIR as of Q1 2025.

  • Point72 Asia (Singapore) reported no remaining Vir Biotechnology position as of Q1 2025 after selling out during the quarter.
  • Point72 Asia (Singapore) sold 5,690 Vir Biotechnology shares in Q1 2025, an estimated $41.8K.
  • Point72 Asia (Singapore) first reported a position in Vir Biotechnology in Q1 2024 and held it in 3 quarters.
  • Point72 Asia (Singapore)'s Vir Biotechnology position peaked at $169K in Q2 2024.
  • 233 funds tracked by Wall St. Rank held Vir Biotechnology as of Q1 2025.

Based on Point72 Asia (Singapore)'s 13F filing for Q1 2025, filed 15 May 2025.